Modulation of oxygen consumption rate and vascular endothelial growth factor mRNA expression in human malignant glioma cells by hypoxia

British Journal of Cancer

Volumn 80, Issue 1-2, 1999, Pages 104-109

  Allalunis Turner, M J ^a,b   Franko, A J ^a,b   Parliament, M B ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CROSS CANCER INSTITUTE   (Canada)

Author keywords

Angiogenesis; Glioma; Hypoxia; Oxygen consumption rate; VEGF

Indexed keywords

MESSENGER RNA; VASCULOTROPIN;

ARTICLE; CELL HYPOXIA; CELL LINE; CONTROLLED STUDY; GENE INDUCTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; NORTHERN BLOTTING; OXYGEN CONCENTRATION; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; STRESS;

BLOTTING, NORTHERN; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN CONSUMPTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032945925     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690328     Document Type: Article

References (34)

1. Allalunis-Turner MJ and Siemann DW (1986) Characterization of human tumor xenografts using different enzyme dissociation techniques. Br J Cancer 54: 615-622
2. Allalunis-Turner MJ, Barron GM, Day RS, III, Fulton DS and Urtasun RC (1992) Radiosensitivity testing of human primary brain tumor specimen. Int J Radiat Oncol Biol Phys 23: 339-343
3. Berkman RA, Merrill MJ, Reinhold WC, Monacci WT, Saxena A, Clark WC, Robertson JT, Ali IU and Oldfield EH (1993) Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin lnvest 91: 153-159
4. Berse B, Brown LF, Van De Water L, Dvorak HF and Senger DR (1992) Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages and tumors. Mol Biol Cell 3: 211-220
5. Boag JW (1970) Cell respiration as a function of oxygen tension. Int J Radiat Biol 5: 475-478
6. Brooks D (1990) In-vivo metabolism of human cerebral tumors. In Neuro-Oncology: Primary Malignant Brain Tumors, Thomas D (ed.), pp. 122-134. Johns Hopkins University Press: Baltimore
7. Bussolino F, Mantovani A and Persico G (1997) Molecular mechanisms of blood vessel formation. Trends Biol Sci 22: 251-256
8. Chandel NS, Budinger GRS, Choe SH and Schumaker PT (1997) Cellular respiration during hypoxia. J Biol Chem 272, 18808-18816.
9. Dewhirst MW, Secomb TW, Ong ET, Hsu R and Gross JF (1994) Determination of local oxygen consumption rates in tumors. Cancer Res 54: 3333-3336
10. Dvorak HF, Brown LF, Detmar M and Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039
11. Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y and Fujii-Kuriyama Y (1997) A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1a regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA 94: 4273-4278
12. Erecinska M and Wilson DF (1982) Regulation of cellular energy metabolism. J Membr Biol 70: 1-14
13. Ferrara N, Houck K, Jakeman L and Leung DW (1992) Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocrinol Rev 13: 18-29
14. Fontanini G, Vignati S, Boldrini L, Chiné S, Silvestri V, Lucchi M, Mussi A, Angeletti AA and Bevilacqua G (1997) Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma. Clin Cancer Res 3: 861-865
15. Froese G (1962) The respiration of ascites tumor cells at low oxygen concentrations. Biochim Biophys Acta 57: 509-519
16. Hanahan D and Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86: 353-364
17. Hochachka PW and Guppy M (1987) Animal anaerobes. In Metabolic Arrest and the Control of Biological Time, pp. 10-35. Harvard University Press: Cambridge
18. Hochachka PW, Buck LT and Land SC (1996) Unifying theory of hypoxia tolerance: molecular/metabolic defense and rescue mechanisms for surviving oxygen lack. Proc Natl Acad Sci USA 93: 9493-9498
19. Houck KA, Leung DW, Rowland AM, Winter J and Ferrara N (1992) Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms. Biol Chem 267: 26031-26037
20. Iliopoulos O, Levy AP, Jiang C, Kaeling WG Jr and Goldberg MA (1996) Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 93: 10595-10599
21. Koch CJ (1984) A 'thin film' culturing technique allowing rapid gas-liquid equilibrium (6 seconds) with no toxicity to mammalian cells. Radiat Res 97: 434-438
22. Koch CJ, Howell RL and Biaglow JE (1979) Ascorbate anion potentiates the cytotoxicity of nitro-aromatic compounds under hypoxic and anoxic conditions. Br J Cancer 39: 321-329
23. Lammertsma MA, Wise R, Cox T, Thomas D and Jones T (1985) Measurement of blood flow, oxygen utilization, oxygen extraction ratio and fractional blood volume in human brain tumours and surrounding oedematous tissue. Br J Radiol 58: 725-734
24. Leith JT and Michelson S (1995) Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif 28: 415-430
25. Levy AP, Levy NS and Goldberg MA (1996) Post-transcriptional regulation of vascular endothelial growth factor by hypoxia. J Biol Chem 271: 2746-2653
26. Levy AP, Levy NS, Iliopoulos O, Jiang C, Kaelin WG Jr and Goldberg MA (1997) Regulation of vascular endothelial growth factor by hypoxia and its modification by the von-Hippel-Lindau tumor suppressor gene. Kidney Int 51: 575-578
27. Ohta Y, Endo Y, Tanaka M, Shimizu J, Oda M, Hayashi Y, Watanabe Y and Sasaki T (1996) Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer. Clin Cancer Res 2: 1411-1416
28. Parliament MP, Franko AJ, Allalunis-Turner MJ, Mielke BW, Santos CL, Wolokoff BG and Mercer JR (1997) Anomalous patterns of nitroimidazole binding adjacent to necrosis in human glioma xenografts: possible role of decreased oxygen consumption. Br J Cancer 75: 311-318
29. Plate KH, Breier G, Weich HA and Risau W (1992) Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo. Nature 359; 845-848
30. Plate KH, Breier G, Weich HA, Mennel HD and Risau W (1994) Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vitro regulatory mechanisms. Int J Cancer 59: 520-529
31. Salver P, Mäenpää H, Orpana A, Alitalo K and Joensuu H (1997) Serum vascular endothelial growth factor is often elevated in disseminated cancer. Clin Cancer Res 3: 647-651
32. Secomb TW, Hsu R, Ong ET, Gross JF and Dewhirst MW (1995) Analysis of the effects of oxygen supply and demand on hypoxic fraction in tumors. Acta Oncol 34: 313-316
33. Suzuki K, Hayashi N, Miyamoto Y, Yamamoto M, Ohkawa K, Ito Y, Sasaki Y, Yamaguchi Y, Nakase H, Noda K, Enomoto N, Arai K, Yamada Y, Yoshihara H, Tujimura T, Kawano K, Yoshikawa K and Kamada T (1996) Expression of vascular permeability factor/vascular endothelial growth factor in human hepatocellular carcinoma. Cancer Res 56: 3004-3009
34. White FC, Carroll SM, and Kamps MP (1995) VEGF mRNA is reversibly stabilized by hypoxia and persistently stabilized in VEGF-overexpressing human tumor cell lines. Growth Factors 12: 289-301